154 related articles for article (PubMed ID: 10671303)
1. Randomized controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor for the treatment of chronic hepatitis c.
Carreño V; Martín J; Pardo M; Brotons A; Anchía P; Navas S; Fernández M; Arocena C; Quiroga JA
Cytokine; 2000 Feb; 12(2):165-70. PubMed ID: 10671303
[TBL] [Abstract][Full Text] [Related]
2. Interferon alfa-2b alone or combined with recombinant granulocyte-macrophage colony-stimulating factor as treatment of chronic hepatitis C.
Grønbaek K; Krarup HB; Ring-Larsen H; Schaffalitzky de Muckadell O; Møller A; Schlichting P; Vyberg M
Scand J Gastroenterol; 2002 Jul; 37(7):840-4. PubMed ID: 12190100
[TBL] [Abstract][Full Text] [Related]
3. Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis C.
Shiffman ML; Hofmann CM; Luketic VA; Sanyal AJ
J Hepatol; 1998 Mar; 28(3):382-9. PubMed ID: 9551674
[TBL] [Abstract][Full Text] [Related]
4. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
Farrell GC; Bacon BR; Goldin RD
Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor as adjuvant therapy for factor as adjuvant therapy for interferon alpha treatment of chronic hepatitis C.
Carreno V; Parra A; Navas S; Quiroga JA
Cytokine; 1996 Apr; 8(4):318-22. PubMed ID: 9162222
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor and interferon-alpha 2B in patients with advanced renal cell carcinoma.
Lümmen G; Sperling H; Luboldt H; Otto T; Rübben H
Urol Int; 1998; 61(4):215-9. PubMed ID: 10364752
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B.
Martin J; Bosch O; Moraleda G; Bartolome J; Quiroga JA; Carreño V
Hepatology; 1993 Oct; 18(4):775-80. PubMed ID: 8406350
[TBL] [Abstract][Full Text] [Related]
8. Influence of varying doses of granulocyte-macrophage colony-stimulating factor on pharmacokinetics and antibody-dependent cellular cytotoxicity.
Liljefors M; Nilsson B; Mellstedt H; Frödin JE
Cancer Immunol Immunother; 2008 Mar; 57(3):379-88. PubMed ID: 17676322
[TBL] [Abstract][Full Text] [Related]
9. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
[TBL] [Abstract][Full Text] [Related]
10. A preliminary experience with GM-CSF plus interferon in patients with HBV and HCV resistant to interferon therapy.
Van Thiel DH; Friedlander L; Kania RJ; Molloy PJ; Hassanein T; Faruki H
J Viral Hepat; 1997; 4 Suppl 1():101-6. PubMed ID: 9097287
[TBL] [Abstract][Full Text] [Related]
11. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment Group.
Shiffman ML; Hofmann CM; Gabbay J; Luketic VA; Sterling RK; Sanyal AJ; Contos MJ; Ryan MJ; Yoshida C; Rustgi V
Am J Gastroenterol; 2000 Oct; 95(10):2928-35. PubMed ID: 11051370
[TBL] [Abstract][Full Text] [Related]
13. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
14. Combination treatment of advanced HCV associated liver disease with interferon and G-CSF.
Van Thiel DH; Faruki H; Friedlander L; Fagiuoli S; Caraceni P; Molloy PJ; Kania RJ; Wright HI
Hepatogastroenterology; 1995; 42(6):907-12. PubMed ID: 8847044
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients.
Cotonat T; Quiroga JA; López-Alcorocho JM; Clouet R; Pardo M; Manzarbeitia F; Carreño V
Hepatology; 2000 Feb; 31(2):502-6. PubMed ID: 10655277
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial.
Sherman KE; Sjogren M; Creager RL; Damiano MA; Freeman S; Lewey S; Davis D; Root S; Weber FL; Ishak KG; Goodman ZD
Hepatology; 1998 Apr; 27(4):1128-35. PubMed ID: 9537454
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection.
McHutchison JG; Giannelli G; Nyberg L; Blatt LM; Waite K; Mischkot P; Pianko S; Conrad A; Grint P
J Interferon Cytokine Res; 1999 Nov; 19(11):1265-70. PubMed ID: 10574619
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
Tong MJ; Reddy KR; Lee WM; Pockros PJ; Hoefs JC; Keeffe EB; Hollinger FB; Hathcote EJ; White H; Foust RT; Jensen DM; Krawitt EL; Fromm H; Black M; Blatt LM; Klein M; Lubina J
Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow suppression or active proliferation? An analysis of neutropenia after pegylated interferon treatment of patients with chronic hepatitis C.
Liu YL; Du XF; Chen XY; Ma LN; Guo DD; Lu JF; Cao ZH; Zhang YH
Scand J Infect Dis; 2013 Dec; 45(12):939-43. PubMed ID: 24090457
[TBL] [Abstract][Full Text] [Related]
20. IFN-alpha2b monotherapy in patients with chronic hepatitis C and persistently normal or near normal aminotransferase activity: a randomized, controlled study.
Tassopoulos NC; Vafiadis I; Tsantoulas D; Syrokosta J; Hatzis G; Delladetsima JK; Demonakou M; Sypsa V; Hatzakis AE
J Interferon Cytokine Res; 2002 Mar; 22(3):365-9. PubMed ID: 12034044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
